nitroglicerina 50 mg /10 ml solucion inyectable infusion i.v.
laboratorio sanderson, s.a. - nitroglicerina (diluÍda 1 % p/p) - nitroglicerina (diluÍda 1 % p/p)....50 mg.
nitroglicerina usp 5mg/ml solución inyectable para infusión
flagship biotech international pvt ltd - nitroglicerina - nitroglicerina....5.00 mg
cardioplast
mcdermott laboratories ltd t/a gerard laboratories - nitroglycerin (glyceryl trinitrate) - transdermal patch - 0.4 - glyceryl trinitrate
cardioplast
mcdermott laboratories ltd t/a gerard laboratories - nitroglycerin (glyceryl trinitrate) - transdermal patch - 0.2 - glyceryl trinitrate
cardioplast
mcdermott laboratories ltd t/a gerard laboratories - nitroglycerin (glyceryl trinitrate) - transdermal patch - 0.6 - glyceryl trinitrate
adempas
bayer ag - riociguat - hypertension, pulmonary - antihypertensives for pulmonary arterial hypertension - chronic thromboembolic pulmonary hypertension (cteph) adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah) adempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. efficacy has been shown in a pah population including aetiologies of idiopathic or heritable pah or pah associated with connective tissue disease.
minitran- nitroglycerin patch
kindeva drug delivery l.p. - nitroglycerin (unii: g59m7s0ws3) (nitroglycerin - unii:g59m7s0ws3) -
cafinitrina 20 comprimits recub sublinguals
nitroplast 15 mg/24 h 500 pegats transdèrmics 56,2mg
nitroplast 10 mg/24 h 500 pegats transdèrmics 37,4mg